<DOC>
	<DOC>NCT01255267</DOC>
	<brief_summary>In this study, we evaluate the acute coronary syndrome patients to see if there is correlation between platelet activity, genetic polymorphism (CYP2C19 and ABCB1), serum adipokines level, and Clopidogrel responsiveness.</brief_summary>
	<brief_title>The Correlation Between Genetic Polymorphism, Platelet Activity, Clopidogrel Responsiveness, and Serum Adipokine Concentration in Asian Acute Coronary Syndrome Patients</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>1. Age &gt; 18 y/o 2. Acute coronary syndrome patients 3. Chronic coronary artery disease patients 4. Healthy volunteers 1. Patient refusal 2. Allergy to Clopidogrel 3. Receive Gp IIb/IIIa inhibitor simultaneously 4. Cancer history 5. Severe renal and liver function impairment 6. Coagulopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Acute coronary syndrome and chronic coronary artery disease patients</keyword>
</DOC>